(CLOSED) NIH PAR-19-215 Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed)

Sponsor Name: 
NIH
Description of the Award: 

The NIH Research Education Program (R25) supports research educational activities that complement other formal training programs in the mission areas of the NIH Institutes and Centers. The over-arching goals of the NIH R25 program are to: (1) complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs; (2) encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research; (3) help recruit individuals with specific specialty or disciplinary backgrounds to research careers in biomedical, behavioral and clinical sciences; and (4) foster a better understanding of biomedical, behavioral and clinical research and its implications.

The over-arching goal of this NIBIB R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on:

  • Courses for Skills Development: For example, courses and programs that, using a team-based design approach, incorporate state-of-the-art best practices (such as multidisciplinary/interdisciplinary education, the regulatory pathway and other issues related to the commercialization of medical devices, and the immersion of engineering students in a clinical environment) and further enhance these with novel creative and/or ground-breaking approaches and activities which will be implemented and evaluated with the goal of disseminating the outcomes for the benefit of the larger biomedical engineering education community.

Research education programs may complement ongoing research training and education occurring at the applicant institution, but the proposed educational experiences must be distinct from those training and education programs currently receiving Federal support. R25 programs may augment institutional research training programs (e.g., T32, T90) but cannot be used to replace or circumvent Ruth L. Kirschstein National Research Service Award (NRSA) programs.

Limit (Number of applicants permitted per institution): 
1
Sponsor Final Deadline: 
May 28, 2020
OVPR Application or NOI Instructions: 

Interested applicants should upload the following documents in sequence in one PDF file (File name: Last name_NIH-19-215_2020 no later than 4:00 p.m. on the internal submission deadline:

1. Cover Letter (1 page, pdf):

  • Descriptive title of proposed activity
  • PI name, departmental affiliations(s) and contact information
  • Co-PI's names and departmental affiliation(s)
  • Names of other key personnel
  • Participating institution(s)
  • Number and title of this funding opportunity

2. Project Description (no more than 2 pages, pdf) and identify the project scope that addresses the key aspects and elements, principal investigators, collaborators, and partner organizations.

3. 2-page CV's of Investigators

Formatting Guidelines:

Font/size: Times New Roman (12 pt.)
Document margins: 1.0” (top, bottom, left and right)
Standard paper size (8 ½” x 11)
Questions concerning the limited submissions process may be submitted to limitedsubs@psu.edu.

To be considered as a Penn State institutional nominee, please submit a notice of intent by the date provided directly below.
This limited submission is in downselect: 
Penn State may only submit a specific number of proposals to this funding opportunity. The number of NOIs received require that an internal competition take place, thus, a downselect process has commenced. No Penn State researchers may apply to this opportunity outside of this downselect process. To apply for this limited submission, please use this link:
OVPR Downselect Deadline: 
Thursday, April 23, 2020 - 4:00pm
Notes: 
Gregory Lewis (CoM)